Euroapi S.A. (EPA:EAPI)
France · Delayed Price · Currency is EUR 0.8520
+0.0260 (3.15%)
Sep 11, 2026, 5:35 PM CET
Euroapi Revenue
Euroapi had revenue of 356.50M EUR in the half year ending June 30, 2026, a decrease of -20.94%. This brings the company's revenue in the last twelve months to 794.60M, down -9.99% year-over-year. In the year 2025, Euroapi had annual revenue of 852.60M, down -7.25%.
Revenue (ttm)
794.60M
Revenue Growth
-9.99%
P/S Ratio
0.10
Revenue / Employee
268.36K
Employees
2,961
Market Cap
81.39M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 852.60M | -66.60M | -7.25% |
| Dec 31, 2024 | 919.20M | -99.70M | -9.79% |
| Dec 31, 2023 | 1.02B | 38.00M | 3.87% |
| Dec 31, 2022 | 980.90M | 88.10M | 9.87% |
| Dec 31, 2021 | 892.80M | -51.80M | -5.48% |
| Dec 31, 2020 | 944.60M | 28.80M | 3.14% |
| Dec 31, 2019 | 915.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Guerbet | 798.67M |
| Eurofins-Cerep | 41.10M |
| ABIONYX Pharma | 4.06M |
| Adocia | 3.85M |
Euroapi News
- 6 weeks ago - Euroapi Earnings Call Transcript: H1 2026 - Transcripts
- 6 weeks ago - Euroapi Earnings release: H1 2026 - Filings
- 6 weeks ago - Euroapi Slides: H1 2026 - Filings
- 6 weeks ago - Euroapi Quarterly report: H1 2026 - Filings
- 3 months ago - Euroapi Transcript: AGM 2026 - Transcripts
- 3 months ago - Euroapi Slides: FY 2026 - Filings
- 4 months ago - EUROAPI statement regarding the Brindisi site - GlobeNewsWire
- 5 months ago - EUROAPI - Availability of the 2025 Universal Registration Document - GlobeNewsWire